| Gina Farinholt, MD | |
|
9850 Genesee Ave, Suite 570, La Jolla, CA 92037-1224 | |
| (858) 457-4917 | |
| (858) 457-3287 |
| Full Name | Gina Farinholt |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 17 Years |
| Location | 9850 Genesee Ave, La Jolla, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992962765 | NPI | - | NPPES |
| GE185Z | Other | MEIDCARE P10 |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | A106135 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hospital - Zion | San diego, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern California Permanente Medical Group | 6002729175 | 7951 |
News Archive
Dangerous airborne viruses are rendered harmless on-the-fly when exposed to energetic, charged fragments of air molecules, University of Michigan researchers have shown.
Peripheral arterial disease is a common circulation problem in which reduced blood flow can lead to complications that jeopardize the limbs, possibly even requiring amputation. Procedures known as revascularization have reduced the need for amputations 40 percent over two decades, Mayo Clinic research shows.
A new use of the drug Herceptin appears to offer a much more powerful treatment advantage than expected for patients with HER-2-positive breast cancer, say researchers at The University of Texas M. D. Anderson Cancer Center.
Since the advent of the Human Genome Project an explosion of data has sent the science world scrambling. There is a growing demand to fine-tune genomic codes, which list the "ingredients for life," but do not adequately explain how those ingredients function. A Rutgers University-Camden biochemist is addressing this knowledge gap through the creation of a database for quick "background checks" on all known enzyme functions. Thanks to a National Institute of Health grant, Peter Palenchar, an assistant professor of chemistry at Rutgers-Camden, will categorize decades-worth of scholarship on enzymes into a database, beginning with those that bind to molecules that contain adenosine.
Researchers are now investigating how to make cancer cells "terminally ill" by giving a common reovirus to patients with various types of cancers.
› Verified 7 days ago
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
Dangerous airborne viruses are rendered harmless on-the-fly when exposed to energetic, charged fragments of air molecules, University of Michigan researchers have shown.
Peripheral arterial disease is a common circulation problem in which reduced blood flow can lead to complications that jeopardize the limbs, possibly even requiring amputation. Procedures known as revascularization have reduced the need for amputations 40 percent over two decades, Mayo Clinic research shows.
A new use of the drug Herceptin appears to offer a much more powerful treatment advantage than expected for patients with HER-2-positive breast cancer, say researchers at The University of Texas M. D. Anderson Cancer Center.
Since the advent of the Human Genome Project an explosion of data has sent the science world scrambling. There is a growing demand to fine-tune genomic codes, which list the "ingredients for life," but do not adequately explain how those ingredients function. A Rutgers University-Camden biochemist is addressing this knowledge gap through the creation of a database for quick "background checks" on all known enzyme functions. Thanks to a National Institute of Health grant, Peter Palenchar, an assistant professor of chemistry at Rutgers-Camden, will categorize decades-worth of scholarship on enzymes into a database, beginning with those that bind to molecules that contain adenosine.
Researchers are now investigating how to make cancer cells "terminally ill" by giving a common reovirus to patients with various types of cancers.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gina Farinholt, MD 9850 Genesee Ave, Suite 570, La Jolla, CA 92037-1224 Ph: (858) 457-4917 | Gina Farinholt, MD 9850 Genesee Ave, Suite 570, La Jolla, CA 92037-1224 Ph: (858) 457-4917 |
News Archive
Dangerous airborne viruses are rendered harmless on-the-fly when exposed to energetic, charged fragments of air molecules, University of Michigan researchers have shown.
Peripheral arterial disease is a common circulation problem in which reduced blood flow can lead to complications that jeopardize the limbs, possibly even requiring amputation. Procedures known as revascularization have reduced the need for amputations 40 percent over two decades, Mayo Clinic research shows.
A new use of the drug Herceptin appears to offer a much more powerful treatment advantage than expected for patients with HER-2-positive breast cancer, say researchers at The University of Texas M. D. Anderson Cancer Center.
Since the advent of the Human Genome Project an explosion of data has sent the science world scrambling. There is a growing demand to fine-tune genomic codes, which list the "ingredients for life," but do not adequately explain how those ingredients function. A Rutgers University-Camden biochemist is addressing this knowledge gap through the creation of a database for quick "background checks" on all known enzyme functions. Thanks to a National Institute of Health grant, Peter Palenchar, an assistant professor of chemistry at Rutgers-Camden, will categorize decades-worth of scholarship on enzymes into a database, beginning with those that bind to molecules that contain adenosine.
Researchers are now investigating how to make cancer cells "terminally ill" by giving a common reovirus to patients with various types of cancers.
› Verified 7 days ago
Dr. Howard Takiff, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 760 La Canada St, La Jolla, CA 92037 Phone: 949-981-4018 | |
Mahmoud Malas, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9434 Medical Center Dr Fl 1, La Jolla, CA 92037 Phone: 619-543-6980 Fax: 858-657-5033 | |
Cheryl Lorraine Olson, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9850 Genesee Ave, Suite 660, La Jolla, CA 92037 Phone: 858-452-5054 Fax: 858-452-5097 | |
James G. Schwendig, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9888 Genesee Ave, Lj-601, La Jolla, CA 92037 Phone: 858-626-6350 Fax: 858-626-6354 | |
Angeles Baquerizo, Surgery Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd # 200n, La Jolla, CA 92037 Phone: 858-544-4310 | |
Dr. David Alexander Frankel, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-554-8988 | |
Ayemoethu Ma, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd # Ms 213, La Jolla, CA 92037 Phone: 858-554-8984 Fax: 858-554-5055 |